サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1182002

ヒト生殖技術の世界市場規模調査＆予測、材料生殖技術（不妊治療薬、避妊薬）別、性別、地域別分析、2022-2029年

Global Human Reproductive Technologies Market Size study & Forecast, by Material Reproductive Technology (Infertility drugs, Contraceptive), By Gender and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ヒト生殖技術の世界市場規模調査＆予測、材料生殖技術（不妊治療薬、避妊薬）別、性別、地域別分析、2022-2029年
出版日: 2023年01月05日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト生殖技術は、妊娠や不妊などの問題を抱えているカップルを支援する技術です。

予後予測、避妊、生殖補助医療（ART）、同性間婚などが含まれます。少子化や家族計画の遅れなどの要因により、ヒト生殖技術市場は拡大しています。

全米人口動態統計システムによると、2018年の米国の出生数（速報値）は3,788,235人で、2017年から2％減少し、32年ぶりの低い出生数となっています。したがって、出生率の減少に伴い、市場は予測期間内に成長すると予想されます。一方、不妊症の増加と市場プレーヤーによる研究開発活動の増加は、市場に有利な機会を創出します。しかし、限られた保険適用範囲が、2022年から2029年の予測期間を通して市場成長の妨げとなります。

世界のヒト生殖技術市場の調査において考慮された主要地域は、アジア太平洋、北米、欧州、中南米、その他の地域が含まれます。北米は、肥満による不妊率の上昇、ライフスタイルの変化、妊娠年齢の上昇により、最も高い収益を上げ、市場を独占しています。一方、アジア太平洋地域は、生殖医療技術に対する意識の高まり、欧米型のライフスタイルの普及、ヘルスケア支出の増加などの要因から、予測期間中に大きく成長するものと思われます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的な側面を取り込むように設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細な情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場の潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • ヒト生殖技術市場：地域別、2019年～2029年
    • ヒト生殖技術市場：生殖技術別、2019-2029年
    • ヒト生殖技術市場：性別、2019年～2029年
  • 主な動向
  • 調査手法
  • 調査前提条件

第2章 ヒト生殖技術の世界市場の定義と範囲

  • 調査の目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 世界のヒト生殖技術市場力学

  • ヒト生殖技術市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 出生率の低下
      • 家族計画の遅れ
    • 市場の課題
      • 限られた保険適用範囲
    • 市場機会
      • 不妊症の増加
      • 市場関係者別研究開発活動の活発化

第4章 ヒト生殖技術の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的要因
    • 経済的
    • 社会的
    • 技術的
  • 投資採用モデル
  • アナリストの結論・提言
  • トップ投資機会
  • 主要成功戦略

第5章 リスクアセスメントCOVID-19のインパクト

  • COVID-19が業界に与える全体的な影響の評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ヒト生殖技術の世界市場、生殖工学別

  • 市場スナップショット
  • ヒト生殖技術の世界市場：生殖工学の性能別-ポテンシャル分析
  • ヒト生殖技術の世界市場、生殖工学別推定・予測（2019年～2029年
  • ヒト生殖技術市場、サブセグメント分析
    • 不妊治療薬
    • 避妊薬

第7章 ヒト生殖技術の世界市場：男女別

  • 市場スナップショット
  • ヒト生殖技術の世界市場：性別）、パフォーマンス-ポテンシャル分析
  • ヒト生殖技術の世界市場、性別ごとの推定・予測（2019年～2029年
  • ヒト生殖技術の世界市場、サブセグメント分析
    • 男性
    • 女性

第8章 ヒト生殖技術の世界市場：地域別分析

  • ヒト生殖技術の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • 生殖技術別の推定・予測、2019年～2029年
      • 性別の推定・予測、2019年～2029年
    • カナダ
  • 欧州ヒト生殖技術市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州地域
  • アジア太平洋地域のヒト生殖技術市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのヒト生殖技術市場のスナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • CooperSurgical, Inc.
      • 主要情報
      • 概要
      • 財務情報（データの入手状況により異なります）
      • 製品概要
      • 最近の動向
    • Teva Pharmaceutical Industries
    • AbbVie Inc.
    • Ferring B.V.
    • Merck KGaA
    • Genea Limited
    • Ivftech
    • Bayer AG

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査属性
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Human Reproductive Technologies Market, report scope
  • TABLE 2. Global Human Reproductive Technologies Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Human Reproductive Technologies Market estimates & forecasts by Reproductive Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Human Reproductive Technologies Market estimates & forecasts by Gender 2019-2029 (USD Billion)
  • TABLE 5. Global Human Reproductive Technologies Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Human Reproductive Technologies Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Human Reproductive Technologies Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Human Reproductive Technologies Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Human Reproductive Technologies Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Human Reproductive Technologies Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Human Reproductive Technologies Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Human Reproductive Technologies Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Human Reproductive Technologies Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Human Reproductive Technologies Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Human Reproductive Technologies Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Human Reproductive Technologies Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Human Reproductive Technologies Market
  • TABLE 70. List of primary sources, used in the study of global Human Reproductive Technologies Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Reproductive Technologies Market, research methodology
  • FIG 2. Global Human Reproductive Technologies Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Human Reproductive Technologies Market, key trends 2021
  • FIG 5. Global Human Reproductive Technologies Market, growth prospects 2022-2029
  • FIG 6. Global Human Reproductive Technologies Market, porters 5 force model
  • FIG 7. Global Human Reproductive Technologies Market, pest analysis
  • FIG 8. Global Human Reproductive Technologies Market, value chain analysis
  • FIG 9. Global Human Reproductive Technologies Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Human Reproductive Technologies Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Human Reproductive Technologies Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Human Reproductive Technologies Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Human Reproductive Technologies Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Human Reproductive Technologies Market, regional snapshot 2019 & 2029
  • FIG 15. North America Human Reproductive Technologies Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Human Reproductive Technologies Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Human Reproductive Technologies Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Human Reproductive Technologies Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Human Reproductive Technologies Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Human Reproductive Technologies Market is valued approximately at USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Human Reproductive Technologies assist couples having trouble with pregnancy or infertility issues etc. It includes prognostics, contraception, Assisted Reproductive Technology (ART), and same-sex procreation. The Human Reproductive Technologies market is expanding because of factors such as decreasing birth rate and delayed family planning.

According to the National Vital Statistics System, the preliminary number of births in the United States in 2018 was 3,788,235, a 2% decrease from 2017 and the lowest number of births in 32 years. Thus , with the decreasing birth rate the market is expected to grow in the forecast period Whereas, the rising infertility and growing R&D activities by market players create lucrative opportunities for the market. However, limited insurance coverage hampers the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Human Reproductive Technologies Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market with highest revenue, owing to the rising infertility rates due to obesity, changing lifestyles, and rising age conceptions. Whereas, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing awareness about reproductive technologies, growing adoption of western lifestyle and rising healthcare spending.

Major market players included in this report are:

CooperSurgical, Inc.

Teva Pharmaceutical Industries

AbbVie Inc.

Ferring B.V.

Merck KGaA

Genea Limited

Ivftech

Bayer AG

Recent Developments in the Market:

  • In June 2022- Genea Limited (Genea) is acquired by Liverpool Partners Pty Ltd (LVP). Both companies supply fertility services including IVF across Perth, Sidney, and Melbourne. Fertility services include a range of services, such as Intracytoplasmic Sperm Injection (ICSI), In Vitro Fertilization (IVF), Preimplantation Genetic Testing (PGT), egg-freezing, Ovulation Induction (OI), Intra Uterine Insemination (IUI), and frozen or fresh embryo transfer.

Global Human Reproductive Technologies Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Reproductive Technology, Gender, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Reproductive Technology:

Infertility Drugs

Contraceptive

By Gender:

Male

Female

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Human Reproductive Technologies Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Human Reproductive Technologies Market, by Reproductive Technology, 2019-2029 (USD Billion)
    • 1.2.3. Human Reproductive Technologies Market, by Gender, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Reproductive Technologies Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Reproductive Technologies Market Dynamics

  • 3.1. Human Reproductive Technologies Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Decreasing birth rate
      • 3.1.1.2. Delayed family planning
    • 3.1.2. Market Challenges
      • 3.1.2.1. Limited insurance coverage
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising infertility rate
      • 3.1.3.2. Growing R&D activities by market players

Chapter 4. Global Human Reproductive Technologies Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Human Reproductive Technologies Market, by Reproductive Technology

  • 6.1. Market Snapshot
  • 6.2. Global Human Reproductive Technologies Market by Reproductive Technology Performance - Potential Analysis
  • 6.3. Global Human Reproductive Technologies Market Estimates & Forecasts by Reproductive Technology 2019-2029 (USD Billion)
  • 6.4. Human Reproductive Technologies Market, Sub Segment Analysis
    • 6.4.1. Infertility drugs,
    • 6.4.2. Contraceptive

Chapter 7. Global Human Reproductive Technologies Market, by Gender

  • 7.1. Market Snapshot
  • 7.2. Global Human Reproductive Technologies Market by Gender, Performance - Potential Analysis
  • 7.3. Global Human Reproductive Technologies Market Estimates & Forecasts by Gender 2019-2029 (USD Billion)
  • 7.4. Human Reproductive Technologies Market, Sub Segment Analysis
    • 7.4.1. Male
    • 7.4.2. Female

Chapter 8. Global Human Reproductive Technologies Market, Regional Analysis

  • 8.1. Human Reproductive Technologies Market, Regional Market Snapshot
  • 8.2. North America Human Reproductive Technologies Market
    • 8.2.1. U.S. Human Reproductive Technologies Market
      • 8.2.1.1. Reproductive Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Human Reproductive Technologies Market
  • 8.3. Europe Human Reproductive Technologies Market Snapshot
    • 8.3.1. U.K. Human Reproductive Technologies Market
    • 8.3.2. Germany Human Reproductive Technologies Market
    • 8.3.3. France Human Reproductive Technologies Market
    • 8.3.4. Spain Human Reproductive Technologies Market
    • 8.3.5. Italy Human Reproductive Technologies Market
    • 8.3.6. Rest of Europe Human Reproductive Technologies Market
  • 8.4. Asia-Pacific Human Reproductive Technologies Market Snapshot
    • 8.4.1. China Human Reproductive Technologies Market
    • 8.4.2. India Human Reproductive Technologies Market
    • 8.4.3. Japan Human Reproductive Technologies Market
    • 8.4.4. Australia Human Reproductive Technologies Market
    • 8.4.5. South Korea Human Reproductive Technologies Market
    • 8.4.6. Rest of Asia Pacific Human Reproductive Technologies Market
  • 8.5. Latin America Human Reproductive Technologies Market Snapshot
    • 8.5.1. Brazil Human Reproductive Technologies Market
    • 8.5.2. Mexico Human Reproductive Technologies Market
  • 8.6. Rest of The World Human Reproductive Technologies Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. CooperSurgical, Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Teva Pharmaceutical Industries
    • 9.2.3. AbbVie Inc.
    • 9.2.4. Ferring B.V.
    • 9.2.5. Merck KGaA
    • 9.2.6. Genea Limited
    • 9.2.7. Ivftech
    • 9.2.8. Bayer AG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption